Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Pacific Biosciences
    Registered Vendor
    • Oct 2008
    • 43

    Principal Scientist / Sr. Staff Scientist, Single Molecule Sequencing

    Pacific Biosciences is seeking a Principal Scientist / Sr. Staff Scientist to join a dynamic team developing next generation DNA sequencing technology. This position is in a fast-paced environment, interacting with R&D and Process Development scientists from a variety of backgrounds. The selected individual will be working toward the development of new products for the Pacific Biosciences SMRT™ sequencing system. This will include working cross functionally to design, plan and execute experiments to evaluate, optimize and integrate sequencing reagents, instrumentation and hardware with the goal of delivering system level improvements to Pacific Biosciences sequencing systems. The position primarily involves hands-on laboratory work and data analysis. Presentation of results at both weekly group and weekly department meetings will be required. The individual will share some responsibilities for laboratory and reagent management.

    Position Requirements
    • PhD or equivalent experience in Biophysics, Biochemistry, Molecular Biology, Chemistry or related scientific field
    • Should be able to perform custom analysis of large datasets (R, Matlab, JMP)
    • Technically proficient in general laboratory practices (biochemistry/molecular biology)
    • Familiarity with Bioinformatics workflows is desirable
    • Practical understanding of the kinetics of enzymatic reactions is important to this role
    • Must have excellent problem solving/trouble shooting skills
    • Working knowledge of fluorescence and its application would be helpful
    • Experience working with complex, prototype instrumentation a plus
    • Attention to detail, careful record-keeping, a high level of organization, and good verbal and written communication skills are required
    • Able to manage several projects simultaneously
    • Self-starter who can operate with minimal supervision
    • The successful candidate will enjoy working closely with others as a member of an interdisciplinary team

    All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, national origin, protected veteran status, or on the basis of disability, gender identity, and sexual orientation.

    To Apply:https://chm.tbe.taleo.net/chm03/ats/...cws=1&rid=1617
    http://www.pacificbiosciences.com

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...